Longitudinally Profiling Neutralizing Antibody Response to SARS Coronavirus with Pseudotypes

The severe acute respiratory syndrome–associated coronavirus (SARS-CoV) spike protein (S) is a major target for neutralizing antibodies. Retroviral SARS-CoV S pseudotypes have been constructed and used to develop an in vitro microneutralization assay that is both sensitive and specific for SARS-CoV...

Descripción completa

Detalles Bibliográficos
Autores principales: Temperton, Nigel J., Chan, Paul K., Simmons, Graham, Zambon, Maria C., Tedder, Richard S., Takeuchi, Yasuhiro, Weiss, Robin A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2005
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3298259/
https://www.ncbi.nlm.nih.gov/pubmed/15757556
http://dx.doi.org/10.3201/eid1103.040906

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3298259/
https://www.ncbi.nlm.nih.gov/pubmed/15757556
http://dx.doi.org/10.3201/eid1103.040906

Ejemplares similares